| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 311.359 | 301.665 | 159.444 | 163.917 | 106.753 | 72.574 | 154.475 | 47.820 | 56.877 | 107.813 |
| Total Income - EUR | 324.155 | 307.783 | 164.436 | 164.402 | 107.547 | 73.902 | 156.243 | 52.774 | 58.175 | 111.453 |
| Total Expenses - EUR | 218.613 | 213.610 | 113.090 | 124.311 | 83.561 | 56.383 | 106.302 | 48.402 | 64.123 | 103.187 |
| Gross Profit/Loss - EUR | 105.542 | 94.173 | 51.346 | 40.091 | 23.986 | 17.519 | 49.941 | 4.372 | -5.948 | 8.266 |
| Net Profit/Loss - EUR | 89.203 | 79.549 | 49.714 | 38.433 | 22.911 | 16.724 | 48.760 | 3.914 | -6.455 | 5.868 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biosan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 381.554 | 55.087 | 22.694 | 2.632 | 10.783 | 3.372 | 3.305 | 30.449 | 21.238 | 12.580 |
| Current Assets | 179.428 | 239.457 | 120.753 | 177.076 | 140.340 | 143.060 | 281.811 | 34.216 | 44.673 | 49.065 |
| Inventories | 27.038 | 15.615 | 12.963 | 7.733 | 6.529 | 8.679 | 6.955 | 5.622 | 8.312 | 3.844 |
| Receivables | 48.820 | 43.729 | 33.654 | 37.162 | 24.932 | 9.077 | 142.066 | 14.896 | 26.008 | 16.410 |
| Cash | 103.570 | 180.113 | 74.137 | 132.181 | 108.879 | 125.303 | 132.790 | 13.697 | 10.353 | 28.811 |
| Shareholders Funds | 510.479 | 79.602 | 127.969 | 164.054 | 139.423 | 131.742 | 177.580 | 3.963 | -2.505 | 3.377 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 50.503 | 214.956 | 15.649 | 15.786 | 11.815 | 14.782 | 107.635 | 58.591 | 67.047 | 57.760 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.661 | 1.895 | 1.131 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1611 - 1611" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Biosan Srl